Nutritional supplements that may be helpful: The mainstay of
treatment for pancreatic insufficiency is replacement of
digestive enzymes, using supplements prepared from pig pancreas (pancrelipase) or
fungi.22 Enzyme supplements have been shown to reduce steatorrhea23
24 associated with pancreatitis, while pain reduction has been demonstrated in
some,25 26 though not all,27 28 double-blind
studies. Digestive enzyme preparations that are resistant to the acidity of the stomach are
effective at lower doses compared with conventional digestive enzyme
preparations.29 Some enzyme preparations are produced with higher lipase enzyme
content for improved fat absorption, but one controlled study of chronic pancreatitis found no
advantage of this preparation over one with standard lipase content.30 People with
more severe pancreatic insufficiency or who attempt to eat a higher-fat diet require more
enzymes,31 but large amounts of pancreatic digestive enzymes are known to damage
the large intestine in some people with diseases causing pancreatic
insufficiency.32 33 34 Therefore, a qualified healthcare
practitioner should be consulted about the appropriate and safe amount of enzymes to use.
Many, otherwise healthy people suffer from
indigestion, and some doctors believe that mild pancreatic insufficiency can be a cause of
indigestion. A preliminary study of people with indigestion reported significant improvement
in almost all of those given pancreatic enzyme supplements.35 One double-blind
trial found that giving pancreatic enzymes to healthy people along with a high-fat meal
reduced bloating, gas, and abdominal fullness following the meal.36
Stomach surgery patients often have decreased pancreatic function, malabsorption, and abdominal symptoms, including
steatorrhea, but digestive enzyme supplementation had no effect on steatorrhea in two of three
double-blind studies of stomach surgery patients,37 38 39
although some other symptoms did improve.40 41 Patients who have surgery
to remove part of the pancreas often have severe steatorrhea that is difficult to control with
enzyme supplements.42 In one double-blind study, neither high-dose nor
standard-dose pancreatin was able to eliminate steatorrhea in over half of the pancreas
surgery patients studied.43
Fat malabsorption in pancreatic insufficiency may result in deficiencies of fat-soluble
vitamins, and these deficiencies may not always be prevented by enzyme
supplementation.44 45 46 One controlled study found that
patients with chronic pancreatitis had vision abnormalities that are associated with vitamin A
deficiency.47 A controlled study of patients with steatorrhea found that a
water-soluble form of vitamin A was easier to absorb than
conventional fat-soluble forms of vitamin A, resulting in vitamin A absorption equal to that
of healthy people.48 Two controlled studies of patients with chronic pancreatitis
found evidence of vitamin E deficiency in their blood.49 50 People with
more severe fat malabsorption tended to have the lowest vitamin E levels. Although doctors
sometimes recommend supplementation with fat-soluble vitamins for people with
pancreatitis,51 no research has investigated the benefits of these supplements.
Pancreatic enzymes are also necessary for the absorption of vitamin B12.52 While people with pancreatic
insufficiency have some malabsorption of this vitamin, true deficiency is considered
rare.53 54 55 No research has investigated whether long-term
vitamin B12 supplementation is beneficial for chronic pancreatitis.
Free radical damage has been linked to pancreatitis in animal and human
studies,56 57 58 suggesting that antioxidants might be beneficial for this disease. One
controlled study found that chronic pancreatitis patients consumed diets significantly lower
in several antioxidants due to problems such as appetite loss and abdominal
symptoms.59 Several controlled studies found lower blood levels of antioxidants,
such as selenium, vitamin A, vitamin E, vitamin C,
glutathione, and several carotenoids, in patients with
both acute and chronic pancreatitis.60 61 62 63
64 65
There are few controlled trials of antioxidant supplementation to patients with
pancreatitis. One small controlled study of acute pancreatitis patients found that sodium
selenite at a dose of 500 micrograms (mcg) daily resulted in decreased levels of a marker of
free radical activity, and no patient deaths occurred.66 In a small double-blind
trial including recurrent acute and chronic pancreatitis patients, supplements providing daily
doses of 600 mcg selenium, 9,000 IU beta-carotene, 540 mg vitamin
C, 270 IU vitamin E, and 2,000 mg methionine significantly reduced pain, normalized several blood
measures of antioxidant levels and free radical activity, and prevented acute recurrences of
pancreatitis.67 These researchers later reported that continuing antioxidant
treatment in these patients for up to five years or more significantly reduced the total
number of days spent in the hospital and resulted in 78% of patients becoming pain-free and
88% returning to work.68
In a preliminary report, three patients with chronic pancreatitis were treated with grape seed extract in the amount of 100 mg 2–3
times per day. The frequency and intensity of abdominal pain was reduced in all three
patients, and there was a resolution of vomiting in one patient.69
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
References:
1. Wormsley, KG. Pancreatic exocrine function in patients with gastric
ulceration before and after gastrectomy. Lancet 1972;7779:682–4.
2. Dimagno, EP, Go, VLW, Summerskill WHJ. Impaired
cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in
sprue. Gastroenterology 1972;63:25–32.
3. Hegnhoj J, Hansen CP, Rannem T, et al. Pancreatic function in
Crohn’s disease. Gut 1990;31:1076–9.
4. D’Ambrosi A, Verzola A, Gennaro P, et al. Functional reserve of
the exocrine pancreas in Sjögren’s syndrome. Recenti Prog Med
1997;88:21–5 [in Italian].
5. Dreiling DA, Soto JM. The pancreatic involvement in disseminated
“collagen” disorders. Am J Gastroenterology 1976;66:546–53.
6. Watts RA, Isenberg DA. Pancreatic disease in the autoimmune rheumatic
disorders. Semin Arthritis Rheum 1989;19:158–65 [review].
7. Apte MV, Keogh GW, Wilson JS. Chronic pancreatitis: complications and
management. J Clin Gastroenterol 1999;29:225–40.
8. Sleisenger MH, Feldman M, Scharschmidt BF. Sleisenger &
Fordtran’s Gastrointestinal and Liver Disease Pathophysiology/Diagnosis/Management.
Philadelphia, PA: W.B. Saunders Company, 1998, 818.
9. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in
patients with acute and chronic pancreatitis. Gastroenterol Clin North Am
1999;28:695–707 [review].
10. Nakamura T, Tando Y, Yamada N, et al. Study on pancreatic
insufficiency (chronic pancreatitis) and steatorrhea in Japanese patients with low fat intake.
Digestion 1999;60 Suppl 1:93–6.
11. Dutta SK, Hlasko J. Dietary fiber in pancreatic disease: effect of
high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the
interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr
1985;41:517–25.
12. Matteo A, Sarles H. Is food allergy a cause of acute pancreatitis?
Pancreas 1990;5:234–7.
13. Iwata F, Odajima Y. Acute pancreatitis associated with food allergy.
Eur J Pediatr 1997;156:506 [letter].
14. Gastaminza G, Bernaola G, Camino ME. Acute pancreatitis caused by
allergy to kiwi fruit. Allergy 1998;53:1104–5.
15. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in
patients with acute and chronic pancreatitis. Gastroenterol Clin North Am
1999;28:695–707 [review].
16. Gullo L, Barbara L, Labo G. Effect of cessation of alcohol use on the
course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology
1988;94:1063–8.
17. Kankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W. Natural course in
chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of
the disease. Digestion 1993;54:148–55.
18. Brown P. The influence of smoking on pancreatic function in man.
Med J Aust 1976;2:290–3.
19. Talamini G, Bassi C, Falconi M, et al. Cigarette smoking: an
independent risk factor in alcoholic pancreatitis. Pancreas 1996;12:131–7.
20. Hart AR. Pancreatic cancer: any prospects for prevention?
Postgrad Med J 1999;75:521–6 [review].
21. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Prognosis of chronic
pancreatitis: an international multicenter study. International pancreatitis study group.
Am J Gastroenterol 1994;89:1467–71.
22. Scolapio JS, Malhi-Chowla N, Ukleja A. Nutrition supplementation in
patients with acute and chronic pancreatitis. Gastroenterol Clin North Am
1999;28:695–707 [review].
23. Nakamura T, Tandoh Y, Terada A, et al. Effects of high-lipase
pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in
patients with pancreatic insufficiency resulting from chronic pancreatitis. Int J
Pancreatol 1998;23:63–70.
24. Schneider MU, Knoll-Ruzicka ML, Domshke S, et al. Pancreatic enzyme
replacement therapy: comparative effects of conventional and enteric-coated microspheric
pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis.
Hepatogastroenterology 1985;32:97–102.
25. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme
preparation in chronic pancreatitis. Dig Dis Sci
1983;28:97–102.
26. Slaff J, Jacobson D, Tillman CR, et al. Protease-specific suppression
of pancreatic exocrine secretion. Gastroenterol 1984;87:44–52.
27. Halgreen H, Pedersen NT, Worning H. Symptomatic effect of pancreatic
enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol
1986;21:104–8.
28. Mossner J. Is there a place for pancreatic enzymes in the treatment
of pain in chronic pancreatitis? Digestion 1993;54 Suppl 2:35–9.
29. Schneider MU, Knoll-Ruzicka ML, Domshke S, et al. Pancreatic enzyme
replacement therapy: comparative effects of conventional and enteric-coated microspheric
pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis.
Hepatogastroenterology 1985;32:97–102.
30. Dellhaye M, Meuris S, Gohimont AC, et al. Comparative evaluation of a
high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating
exocrine pancreatic insufficiency in chronic pancreatitis. Eur J Gastroenterol
Hepatol 1996;8:699–703.
31. Malesci A, Mariani A, Mezzi G, et al. New enteric-coated high-lipase
pancreatic extract in the treatment of pancreatic steatorrhea. J Clin Gastroenterol
1994;18:32–5.
32. Bansi DS, Price A, Russell C, Sarner M. Fibrosing colonopathy in an
adult owing to over use of pancreatic enzyme supplements. Gut
2000;46:283–5.
33. Littlewood JM, Wolfe SP. Control of malabsorption in cystic fibrosis.
Paediatr Drugs 2000;2:205–22.
34. Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements
for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus
committee. J Pediatr 1995;127:681–4.
35. Cruz Pinho A. Dispepsia e terapeutica enzimatica de substituicao.
Cadernos Generalista (Lisboa) 1990;78:43–47 [in Portugese].
36. Suarez F, Levitt MD, Adshead J, Barkin JS. Pancreatic supplements
reduce symptomatic response of healthy subjects to a high fat meal. Dig Dis Sci
1999;44:1317–21.
37. Bragelmann R, Armbrecht U, Rosemeyer D, et al. The effect of
pancreatic enzyme supplementation in patients with steatorrhea after total gastrectomy.
Eur J Gastroenterol Hepatol 1999;11:231–7.
38. Armbrecht U, Lundell L, Stockbruegger RW. Nutrient malassimilation
after total gastrectomy and possible intervention. Digestion 1987;37 Suppl
1:56–60.
39. Armbrecht U, Lundell L, Stockbrugger RW. The benefit of pancreatic
enzyme substitution after total gastrectomy. Aliment Pharmacol Ther
1988;2:493–500.
40. Armbrecht U, Lundell L, Stockbruegger RW. The benefit of pancreatic
enzyme substitution after total gastrectomy. Aliment Pharmacol Ther
1988;2:493–500.
41. Bragelmann R, Armbrecht U, Rosemeyer D, et al. The effect of
pancreatic enzyme supplementation in patients with steatorrhea after total gastrectomy.
Eur J Gastroenterol Hepatol 1999;11:231–7.
42. Ghaneh P, Neoptolemos JP. Exocrine pancreatic function following
pancreatectomy. Ann N Y Acad Sci 1999;880:308–18 [review].
43. Neoptolemos JP, Ghaneh P, Andren-Sandberg A, et al. Treatment of
pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized,
double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin. Int
J Pancreatol 1999;25:171–80.
44. Dutta SK, Bustin MP, Russell RM, Costa BS. Deficiency of fat-soluble
vitamins in treated patients with pancreatic insufficiency. Ann Intern Med
1982;97:549–52.
45. Nakamura T, Takebe K, Imamura K, et al. Fat-soluble vitamins in
patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastroenterol
Belg 1996;59:10–4.
46. Layer P, Keller J. Pancreatic enzymes: secretion and luminal nutrient
digestion in health and disease. J Clin Gastroenterol 1999;28:3–10
[review].
47. Toskes PP, Dawson W, Curington C, et al. Non-diabetic retinal
abnormalities in chronic pancreatitis. N Engl J Med
1979;300:942–6.
48. Johnson EJ, Krasinski SD, Howard LJ, et al. Evaluation of vitamin A
absorption by using oil-soluble and water-miscible vitamin A preparations in normal adults and
in patients with gastrointestinal disease. Am J Clin Nutr 1992;55:857–64.
49. Kalvaria I, Labadarios D, Shephard GS, et al. Biochemical vitamin E
deficiency in chronic pancreatitis. Int J Pancreatol 1986;1:119–28.
50. Nakamura T, Takebe K, Imamura K, et al. Fat-soluble vitamins in
patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastroenterol
Belg 1996;59:10–4.
51. Beers MH, Berkow R. The Merck Manual of Diagnosis and
Therapy, 17th ed. Whitehouse Station, NJ: Merck & Co, 1999, 275.
52. Festen HP. Intrinsic factor secretion and cobalamin absorption.
Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol
1991;188:1S–7S [review].
53. Gueant JL, Champigneulle B, Gaucher P, Nicolas JP. Malabsorption of
vitamin B12 in pancreatic insufficiency of the adult and of the child. Pancreas
1990;5:559–67 [review].
54. Bang Jorgensen B, Thorsgaard Pedersen N, Worning H. Short report:
lipid and vitamin B12 malassimilation in pancreatic insufficiency. Aliment Pharmacol
Ther 1991;5:207–10.
55. Loew D, Wanitschke R, Schroedter A. studies on vitamin B12 status in
the elderly—prophylactic and therapeutic consequences. Int J Vitam Nutr Res
1999;69:228–33.
56. Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and
chronic pancreatitis. Am J Clin Nutr 1995;62:1306S–14S [review].
57. Schulz H, Niederau C, Klonowski-Stumpe H, et al. Oxidative stress in
acute pancreatitis. Hepato-Gastroenterology 1999;46:2736–2750 [review].
58. Wallig MA. Xenobiotic metabolism, oxidant stress and chronic
pancreatitis. Digestion 1998;59(suppl 4):13–24 [review].
59. Rose P, Fraine E, Hunt LP, et al. Dietary antioxidants and chronic
pancreatitis. Hum Nutr Clin Nutr 1986;40:151–64.
60. Morris-Stiff GJ, Bowrey DJ, Oleesky D, et al. The antioxidant
profiles of patients with recurrent acute and chronic pancreatitis. Am J
Gastroenterol 1999;94:2135–40.
61. Gut A, Shiel N, Kay PM, et al. Heightened free radical activity in
blacks with chronic pancreatitis at Johannesburg, South Africa. Clin Chim Acta
1994;230:189–99.
62. Bonham MJ, Abu-Zidan FM, Simovic MO, et al. Early ascorbic acid
depletion is related to the severity of acute pancreatitis. Br J Surg
1999;86:1296–301.
63. Tsai K, Wang SS, Chen TS, et al. Oxidative stress: an important
phenomenon with pathogenetic significance in the progression of acute pancreatitis.
Gut 1998;42:850–6.
64. Braganza JM, Schofield D, Snehalatha C, Mohan V. Micronutrient
antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J
Gastroenterol 1993;28:1098–104.
65. Mathew P, Wyllie R, Van Lente F, et al. Antioxidants in hereditary
pancreatitis. Am J Gastroenterol 1996;91:1558–62.
66. Kulinski B, Buchner M, Schweder R, Nagel R. Acute
pancreatitis—a free radical disease. Decrease in fatality with sodium selenite (Na2SeO3)
therapy. Z Gesamte Inn Med 1991;46:145–9 [in German].
67. Uden S, Bilton D, Nathan L, et al. Antioxidant therapy for recurrent
pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther
1990;4:357–71.
68. McCloy R. Chronic pancreatitis at Manchester, UK. Focus on
antioxidant therapy. Digestion 1998;59(suppl 4):36–48 [review].
69. Banerjee B, Bagchi D. Beneficial effects of a novel IH636 grape seed
proanthocyanidin extract in the treatment of chronic pancreatitis. Digestion
2001;63:203–6.